Is social media fueling body image issues and disordered eating? Coronavirus Disease COVID EatingDisorder Socialmedia Bodyimage Disorderedeating ualbany UCSF umnmedschool
By Tarun Sai LomteApr 6 2023Reviewed by Lily Ramsey, LLM In a recent study published in the Eating Behaviors journal, researchers assessed the impact of social media usage on body image and disordered eating behaviors.
While SM offers benefits such as social interactions and peer support, growing evidence suggests the potential negative impact of SM on mental health and quality of life, including possible associations of SM usage with disordered eating and poor body image. In 2022, participants described the impact of the COVID-19 pandemic on SM use. They indicated if the SM networks allowed them to view diverse content and how much they sought content on weight loss and body positivity. Demographics and SM patterns were compared using chi-squared and independent sample t-tests.
Moreover, females had higher SM usage and more SM accounts at either time. Participants in 2022 were more likely to use TikTok, YouTube, and Snapchat and less likely to use Twitter and Facebook compared to 2015 participants. The usage of Instagram was similar between the two samples. Participants in 2022 had a higher frequency of laxative use and vomiting. Most participants in 2022 revealed that SM networks allowed diverse content and included people who looked like them.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Study suggests psychosocial factors, not acute infections, contribute to long-COVID in young adultsStudy suggests psychosocial factors, not acute infections, contribute to long-COVID in young adults COVID PASC PCC LongCOVID psychosocial psychosomatic JAMANetworkOpen
Weiterlesen »
Long COVID linked to increased sick leave rateLong COVID linked to increased sick leave rate Coronavirus Disease COVID LongCOVID PASC medrxivpreprint KommItEksamen UniSouthDenmark koebenhavns_uni
Weiterlesen »
Study assesses the cellular and molecular immunopathology of post-COVID lung diseaseStudy assesses the cellular and molecular immunopathology of post-COVID lung disease medrxivpreprint ucl longcovid COVID19 covid SARSCoV2 lungdisease postcovid news medicalresearch
Weiterlesen »
mAb therapy reduces risk of hospitalization and death against Alpha, Delta, and Omicron variantsmAb therapy reduces risk of hospitalization and death against Alpha, Delta, and Omicron variants Coronavirus Disease COVID Monoclonal Antibody Omicron AnnalsofIM UPMC PittTweet
Weiterlesen »
Trade ministers flag researchers as export ban riskTrade ministers flag researchers as possible vector of tech sanction-busting
Weiterlesen »
Plasma biomarkers for Alzheimer’s disease: a field-test in a memory clinicBackground The key Alzheimer’s disease (AD) biomarkers are traditionally measured with techniques/exams that are either expensive (amyloid-positron emission tomography (PET) and tau-PET), invasive (cerebrospinal fluid Aβ42 and p-tau181), or poorly specific (atrophy on MRI and hypometabolism on fluorodeoxyglucose-PET). Recently developed plasma biomarkers could significantly enhance the efficiency of the diagnostic pathway in memory clinics and improve patient care. This study aimed to: (1) confirm the correlations between plasma and traditional AD biomarkers, (2) assess the diagnostic accuracy of plasma biomarkers as compared with traditional biomarkers, and (3) estimate the proportion of traditional exams potentially saved thanks to the use of plasma biomarkers. Methods Participants were 200 patients with plasma biomarkers and at least one traditional biomarker collected within 12 months. Results Overall, plasma biomarkers significantly correlated with biomarkers assessed through traditional techniques: up to r=0.50 (p|0.001) among amyloid, r=0.43 (p=0.002) among tau, and r=−0.23 (p=0.001) among neurodegeneration biomarkers. Moreover, plasma biomarkers showed high accuracy in discriminating the biomarker status (normal or abnormal) determined by using traditional biomarkers: up to area under the curve (AUC)=0.87 for amyloid, AUC=0.82 for tau, and AUC=0.63 for neurodegeneration status. The use of plasma as a gateway to traditional biomarkers using cohort-specific thresholds (with 95% sensitivity and 95% specificity) could save up to 49% of amyloid, 38% of tau, and 16% of neurodegeneration biomarkers. Conclusion The implementation of plasma biomarkers could save a remarkable proportion of more expensive traditional exams, making the diagnostic workup more cost-effective and improving patient care. Data are available on reasonable request.
Weiterlesen »